Clinical Trials Sponsored by Tanner Center for Multiple Sclerosis

Total 2304 results

Memorial Sloan Kettering Cancer Center
Fox Chase Cancer Center; University of Chicago

Recruiting

A Genotype-Phenotype Urothelial Cancer Registry

Bladder Cancer | Urothelial Cancer | Ureter Cancer | Renal Pelvis Cancer

United States
Clatterbridge Centre for Oncology

Unknown

Early Hospital Discharge or Standard Inpatient Care in Cancer Patients Receiving Antibiotics for Febrile Neutropenia

Lymphoma | Small Intestine Cancer | Neutropenia | Brain and Central Nervous System Tumors | Unspecified Adult Solid Tumor, Protocol Specific | Psychosocial Effects of Cancer and Its Treatment

United Kingdom
Jonsson Comprehensive Cancer Center
National Center for Advancing Translational Sciences (NCATS)

Recruiting

Biologic Association Between Metabolic Magnetic Resonance-positron Emission Tomograph (MR-PET) and Tissue Measures of Glycolysis in Brain Tumors of Infiltrating Glioblastoma Cells

Glioblastoma Multiforme | Epidermal Growth Factor Receptor | Glycolytic Index

United States
Fox Chase Cancer Center
National Cancer Institute (NCI); American Cancer Society, Inc.

Completed

Cervical Cancer Screening Intervention Among Korean American Women

Cervical Carcinoma

United States
Ludwig Institute for Cancer Research
M.D. Anderson Cancer Center; Memorial Sloan Kettering Cancer Center; New York...

Completed

NY-ESO-1 Plasmid DNA (pPJV7611) Cancer Vaccine

Sarcoma | Esophageal Cancer | Prostate Cancer | Bladder Cancer | Non-small Cell Lung Cancer

United States
Fred Hutchinson Cancer Center
Fox Chase Cancer Center; City of Hope Medical Center; Stanford University; Cedars-Sinai... and other collaborators

Completed

A Trial Using Novel Markers to Predict Malignancy in Elevated-Risk Women

Epithelial Ovarian Cancer

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI); Gateway for Cancer Research; Institutional Funding...

Recruiting

EphA2 siRNA in Treating Patients With Advanced or Recurrent Solid Tumors

Advanced Malignant Solid Neoplasm

United States
Memorial Sloan Kettering Cancer Center
Ackerman Institute for Family

Active, not recruiting

Training Model to Advance Support of the Family as a Caregiving System in the Inpatient Oncology Setting

Support of the Family as a Caregiving System

United States
Ludwig Institute for Cancer Research
Radboud University Medical Center

Completed

Phase I/II Dose-escalation Study of Lutetium-177-labeled cG250 in Patients With Advanced Renal Cancer

Metastatic Renal Cell Carcinoma

Netherlands
Princess Maxima Center for Pediatric Oncology
Innovative Therapies For Children with Cancer Consortium; IBFM; Fight Kids Cancer

Not yet recruiting

HEM-iSMART-C: Ruxolitinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies (HEM-iSMART C)

Acute Lymphoblastic Leukemia, in Relapse | Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent | Lymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) Recurrent | Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Refractory | Lymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) Refractory

Netherlands
Princess Maxima Center for Pediatric Oncology
Innovative Therapies For Children with Cancer Consortium; IBFM; Fight Kids Cancer

Not yet recruiting

HEM-iSMART-A: Decitabine / Venetoclax and Navitoclax in Pediatric Patients With Relapsed or Refractory Hematological Malignancies (HEM-iSMART A)

Acute Lymphoblastic Leukemia, in Relapse | Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent | Lymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) Recurrent | Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Refractory | Lymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) Refractory

Netherlands
Princess Maxima Center for Pediatric Oncology
Innovative Therapies For Children with Cancer Consortium; IBFM; Fight Kids Cancer

Not yet recruiting

HEM iSMART-D: Trametinib + Dexamethasone + Chemotherapy in Children With Relapsed or Refractory Hematological Malignancies (HEM-iSMART D)

Acute Lymphoblastic Leukemia, in Relapse | Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent | Lymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) Recurrent | Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Refractory | Lymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) Refractory

Netherlands
Princess Maxima Center for Pediatric Oncology
Innovative Therapies For Children with Cancer Consortium; IBFM; Fight Kids Cancer

Not yet recruiting

HEM-iSMART-B: Dasatinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies (HEM-iSMART B)

Acute Lymphoblastic Leukemia | Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent | Lymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) Recurrent | Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Refractory | Lymphoblastic...

Netherlands
Fox Chase Cancer Center
National Cancer Institute (NCI); Temple University

Completed

Facilitating Follow-Up Adherence for Abnormal Pap Smears (TC3)

Uterine Cervical Neoplasms

United States
Fox Chase Cancer Center
Oryzon Genomics S.A.

Recruiting

Iadademstat in Combination With Paclitaxel in Relapsed/Refractory SCLC and Extrapulmonary High Grade NET

Small-cell Lung Cancer | Neuroendocrine Carcinoma

United States
Fox Chase Cancer Center
Varian Medical Systems

Withdrawn

Local Consolidative Therapy in Colorectal Cancer

Colorectal Cancer Metastatic

United States
Ludwig Institute for Cancer Research
Memorial Sloan Kettering Cancer Center; NYU Langone Health

Completed

Study of ADI-PEG 20 in Patients With Advanced Melanoma

Skin Cancer | Metastatic Melanoma | Neoplasm

United States
Garden State Cancer Center at the Center for Molecular...
National Cancer Institute (NCI)

Completed

Radiolabeled Monoclonal Antibody Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Recurrent Colorectal Cancer or Pancreatic Cancer

Colorectal Cancer | Pancreatic Cancer

United States
Garden State Cancer Center at the Center for Molecular...
National Cancer Institute (NCI)

Completed

Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Lymphoma or Leukemia

Lymphoma | Leukemia

United States
Garden State Cancer Center at the Center for Molecular...
National Cancer Institute (NCI)

Completed

Radioimmunotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage IV Breast Cancer

Breast Cancer

United States
Centre Jean Perrin
National Cancer Institute, France; ARC Foundation for Cancer Research

Completed

Study of LY2228820 With Radiotherapy Plus Concomitant TMZ in the Treatment of Newly Diagnosed Glioblastoma (GLYRad)

Adult Glioblastoma

France
Centre Francois Baclesse
National Cancer Institute, France; ARC Foundation for Cancer Research

Terminated

A Multicenter Trial Assessing the Efficacy and Safety of tamOxifen Plus LY2228820 in Advanced or Metastatic Breast Cancer Progressing on aromatasE Inhibitors (OLYMPE)

Metastatic Breast Cancer | Postmenopausal

France
University of Pennsylvania
Fox Chase Cancer Center

Completed

Penn Biobank Return of Research Results Program

Cardiovascular Diseases | Cancer | Hereditary Cancer | Hereditary Cardiac Amyloidosis

United States
University of Pennsylvania
Fox Chase Cancer Center

Completed

Dendritic Cell Vaccine for High Risk Ovarian Cancer Patients (DC-Ova)

Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Carcinoma

United States
Fox Chase Cancer Center
Millennium Pharmaceuticals, Inc.

Terminated

Study to Assess Safety and Tolerability of MLN8237, In Combination With Erlotinib to Treat Non-Small Cell Lung Cancer

Non-small Cell Lung Cancer Metastatic | Non-small Cell Lung Cancer Recurrent

United States
Fox Chase Cancer Center
Bristol-Myers Squibb

Completed

Study of Cetuximab With and Without Weekly Paclitaxel for Patients With Previously Treated Advanced Urothelial Cancer

Urologic Neoplasm

United States
Memorial Sloan Kettering Cancer Center
Otsuka America Pharmaceutical; Ludwig Institute for Cancer Research

Completed

Busulfan, Melphalan, Fludarabine and T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation Followed by Post Transplantation Donor Lymphocyte Infusions

Multiple Myeloma

United States
University Hospital Heidelberg
German Cancer Research Center; National Center for Tumor Diseases, Heidelberg; German Cancer Aid

Completed

NCT Neuro Master Match - N²M² (NOA-20) (N²M²)

Glioblastoma, Adult

Germany
Garden State Cancer Center at the Center for Molecular...
National Cancer Institute (NCI)

Completed

Radiolabeled Monoclonal Antibody Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Lymphoma or Waldenstrom's Macroglobulinemia

Lymphoma | Leukemia

United States
Garden State Cancer Center at the Center for Molecular...
National Cancer Institute (NCI)

Completed

Radiolabeled Monoclonal Antibody Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory or Recurrent Ovarian Epithelial Cancer

Ovarian Cancer

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI); Alaunos Therapeutics; National Center for Research...

Recruiting

Long-Term Follow-Up of Recipient of Gene Transfer Research

Retroviridae Infections | Cancer

United States
Garden State Cancer Center at the Center for Molecular...

Unknown

Bispecific Antibody in Finding Tumor Cells in Patients With Colorectal Cancer

Colorectal Cancer

United States
Garden State Cancer Center at the Center for Molecular...

Unknown

Radiolabeled Monoclonal Antibody, Combination Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory B-Cell Cancer

Lymphoma | Leukemia

United States
Garden State Cancer Center at the Center for Molecular...
National Cancer Institute (NCI)

Unknown

Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer

Lung Cancer

United States
Garden State Cancer Center at the Center for Molecular...
National Cancer Institute (NCI)

Unknown

Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer

Lung Cancer

United States
M.D. Anderson Cancer Center
National Center for Complementary and Integrative Health (NCCIH)

Recruiting

Developing a Culturally Relevant Supportive Care Program for Black Patients Dealing With Advanced Cancer

Cancer

United States
Barbara Ann Karmanos Cancer Institute
Bristol-Myers Squibb; Janssen Pharmaceuticals; Multiple Myeloma Research Consortium

Recruiting

Iberdomide and Daratumumab as Maintenance Therapy After an Autologous Stem Cell Transplant for Multiple Myeloma (IBEX)

Multiple Myeloma

United States
M.D. Anderson Cancer Center
National Center for Complementary and Integrative Health (NCCIH)

Completed

Yoga Program for Lung Cancer Patients and Caregivers

Lung Cancer

United States
Vassar Brothers Medical Center
Health Quest Systems; Dyson Center for Cancer Care

Completed

Preoperative Massage in Breast Surgery Patients

Breast Cancer | Anxiety | Presurgical Anxiety

United States
Center for International Blood and Marrow Transplant...
M.D. Anderson Cancer Center

Terminated

Matched Unrelated Donor Transplant for Metastatic Renal Cell Carcinoma

Metastatic Renal Cell Carcinoma

United States
Memorial Sloan Kettering Cancer Center
Center for Experimental Therapeutics; F.M. KIRBY FOUNDATION

Recruiting

A Study of Deferoxamine (DFO) in People With Leptomeningeal Metastasis

Leptomeningeal Metastases

United States
National Center for Tumor Diseases, Heidelberg
AstraZeneca; German Cancer Research Center; PharmaMar

Completed

Study of Olaparib/Trabectedin vs. Doctor's Choice in Solid Tumors (NCT-PMO-1603)

Cancers With DNA Repair-Deficiency

Germany
Garden State Cancer Center at the Center for Molecular...

Completed

Radioimmunotherapy With or Without Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Thyroid Cancer

Head and Neck Cancer

United States
Fred Hutchinson Cancer Center
National Center for Complementary and Integrative Health (NCCIH)

Completed

Effects of Garlic Supplements on Drug Metabolism

Healthy

United States
Sunnybrook Health Sciences Centre
Ontario Institute for Cancer Research

Terminated

Hyperpolarized 13C MR Imaging of Lactate in Patients With Locally Advanced Cervical Cancer (LACC) Cervical Cancer

Uterine Cervical Neoplasms

Canada
Queensland Centre for Gynaecological Cancer
Queensland University of Technology

Completed

Barriers for the Uptake of LaparoScopic Hysterectomy (LIgHT)

Hysterectomy

Australia
International Agency for Research on Cancer
Centre Leon Berard

Not yet recruiting

Virtual RealiTy and mUsic in the Oncology SEtting - Phase 1 (VRtuose1)

Breast Cancer

France
Queensland Centre for Gynaecological Cancer
The University of Queensland

Recruiting

Sentinel Node Biopsy in Endometrial Cancer (ENDO-3)

Surgery | Sentinel Lymph Node | Endometrial Cancer Stage I

Australia, United States, Brazil, Singapore, India
Sunnybrook Health Sciences Centre
Ontario Institute for Cancer Research

Terminated

Study of Megestrol Acetate in Grade 2 Endometrioid Endometrial Cancer (MA-EEC)

Endometrial Cancer

Canada
Centre Hospitalier Universitaire Vaudois
Ludwig Institute for Cancer Research

Completed

Immunotherapy of Stage III/IV Melanoma Patients

Melanoma

Switzerland

Clinical Trials Sponsored by Tanner Center for Multiple Sclerosis

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bangladesh

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations